NON-IMMUNOGENIC RECOMBINANT STAPHYLOKINASE VERSUS ALTEPLASE FOR PATIENTS WITH MASSIVE PULMONARY EMBOLISM: A RANDOMIZED OPEN-LABEL, MULTICENTER, PARALLEL-GROUP, NON-INFERIORITY TRIAL, FORPE ArticleKirienko A.I., Leontyev S.G., Tereschenko S.N., Yavelov I.S., Shakhnovich R.M., Erlikh A.D., Talibov O.B., Yarovaya E.B., Semenov A.M., Semenov M.P., Ivanov S.V., Beregovykh V.V., Archakov A.I., Markin S.S., Klein H.V., Veremeychuk P.V., Tarkhanov R.V., Ponomarev E.A., Bobkov V.V., Rabinovich R.M. ...Journal of Thrombosis and Haemostasis. Том 23. 2025. С. 657-667
